Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2020 / Jul / Antibody Analysis for Avian Influenza
Clinical Spectroscopy

Antibody Analysis for Avian Influenza

New device offers a 20-minute test to detect virus antibodies

By Luke Turner 07/07/2020 1 min read

Share

A new portable analyzer can detect anti-avian influenza antibodies in blood serum in just 20 minutes (1). The technology, which consists of liquid crystal molecules, an image sensor, and a microfluidic device, rapidly indicates antibody presence and weighs only 5.5 kg. The researchers who conceived it also developed an accompanying fluorescein-labeled protein reagent, which binds only to the anti-H5 avian influenza antibody.

To conduct the test, serum and reagent are mixed for 15 minutes, then injected into the microfluidic device and measured by a portable fluorescence polarization analyzer. Samples containing bound antibodies and reagent create smaller molecular movements, producing a different degree of polarization. Could the test also be used against COVID-19? “By reproducing fragments of spike proteins expressed in the novel coronavirus to use as the reagent, the analyzer should be able to detect anti-coronavirus antibodies,” said Hokkaido University’s Manabu Tokeshi (2).

Credit: Keine Nishiyama et al. (1).

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. K Nishiyama et al., Sens Actuators B Chem, 316 (2020). PMID: 32322135.
  2. Hokkaido University (2020). Available at: https://bit.ly/3i82hXk.

About the Author(s)

Luke Turner

While completing my undergraduate degree in Biology, I soon discovered that my passion and strength was for writing about science rather than working in the lab. My master’s degree in Science Communication allowed me to develop my science writing skills and I was lucky enough to come to Texere Publishing straight from University. Here I am given the opportunity to write about cutting edge research and engage with leading scientists, while also being part of a fantastic team!

More Articles by Luke Turner

False

Advertisement

Recommended

False

Related Content

 This Week’s Mass Spec News
Clinical
This Week’s Mass Spec News

April 4, 2025

2 min read

Spit It Out
Clinical
Spit It Out

December 4, 2024

1 min read

Saliva-based PA-MS test detects paracetamol overdose in just 10 minutes

Let Me See That Brain
Clinical
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

Meeting Mpox Where It’s At
Clinical
Meeting Mpox Where It’s At

December 17, 2024

1 min read

New optical biosensor offers mpox virus detection in 20 minutes

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.